Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DeepSight Technology
Santa Clara, California, United States
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
DeepSight Technology has achieved FDA 510(k) clearance for its NeedleVue™ LC1 Ultrasound System, validating clinical utility for real-time, sub-millimeter instrument visualization; further clearances and clinical adoption are planned[3][1].
- Therapeutic areas
- CardiovascularOncologyOtherNeurology
- Modalities
- DeviceUltrasound-guided instrument (medical device modality)
- Industry
- Medical Imaging
02
Partnerships
Strategic partnerships with OEMs (undisclosed)[1]Collaboration with Siemens for engineering/software[6]Partnered with multiple venture investors (see below)
Beyond the preview
Go deeper on DeepSight Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DeepSight Technology.